Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

P J Cagnoni; T J Walsh; M M Prendergast; D Bodensteiner; S Hiemenz; R N Greenberg; C A Arndt; M Schuster; N Seibel; V Yeldandi

doi:10.1200/JCO.2000.18.12.2476

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Identifier:nobleid.org/w1/20260515/B87F89FD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B87F89FD.svg?ark=w1%2F20260515%2FB87F89FD)](https://nobleid.org/work/w1/20260515/B87F89FD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Identifier:nobleid.org/w1/20260515/B87F89FD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B87F89FD.svg?ark=w1%2F20260515%2FB87F89FD)](https://nobleid.org/work/w1/20260515/B87F89FD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work